95 related articles for article (PubMed ID: 11837384)
41. Monitoring of human Cytomegalovirus infection by antigenemia and viremia in the first 100 days following renal transplantation and relation to antiviral strategies.
Terlizzi ME; Costa C; Astegiano S; Sidoti F; Vendrame R; Segoloni GP; Bergallo M; Cavallo R
Minerva Med; 2008 Jun; 99(3):231-9. PubMed ID: 18497721
[TBL] [Abstract][Full Text] [Related]
42. Monitoring for cytomegalovirus infection in organ transplant recipients: analysis of pp65 antigen, DNA and late mRNA in peripheral blood leukocytes.
Gaeta A; Nazzari C; Angeletti S; Lazzarini M; Mazzei E; Mancini C
J Med Virol; 1997 Nov; 53(3):189-95. PubMed ID: 9365881
[TBL] [Abstract][Full Text] [Related]
43. Human cytomegalovirus immediate early and late transcripts in peripheral blood leukocytes: diagnostic value in renal transplant recipients.
Meyer-König U; Serr A; von Laer D; Kirste G; Wolff C; Haller O; Neumann-Haefelin D; Hufert FT
J Infect Dis; 1995 Mar; 171(3):705-9. PubMed ID: 7876623
[TBL] [Abstract][Full Text] [Related]
44. Monitoring of CMV infection: a comparison of PCR from whole blood, plasma-PCR, pp65-antigenemia and virus culture in patients after bone marrow transplantation.
Hebart H; Müller C; Löffler J; Jahn G; Einsele H
Bone Marrow Transplant; 1996 May; 17(5):861-8. PubMed ID: 8733710
[TBL] [Abstract][Full Text] [Related]
45. [pp65 antigenemia in evaluation of cytomegalovirus infection after kidney transplantation].
Orlić P; Dvornik S; Husnjak SC; Aralica M; Orlić L; Zivcić-Cosić S; Sladoje-Martinović B; Fućak M
Acta Med Croatica; 2003; 57(1):49-52. PubMed ID: 12876863
[TBL] [Abstract][Full Text] [Related]
46. Relationship of cytomegalovirus load assessed by real-time PCR to pp65 antigenemia in organ transplant recipients.
Sanghavi SK; Abu-Elmagd K; Keightley MC; St George K; Lewandowski K; Boes SS; Bullotta A; Dare R; Lassak M; Husain S; Kwak EJ; Paterson DL; Rinaldo CR
J Clin Virol; 2008 Aug; 42(4):335-42. PubMed ID: 18495527
[TBL] [Abstract][Full Text] [Related]
47. Early diagnosis and monitoring of active HCMV infection in children with systemic lupus erythematosus.
Zhang C; Shen K; Jiang Z; He X
Chin Med J (Engl); 2001 Dec; 114(12):1309-12. PubMed ID: 11793860
[TBL] [Abstract][Full Text] [Related]
48. Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infection.
Alain S; Hantz S; Scieux C; Karras A; Mazeron MC; Szelag JC; Imbert BM; Fillet AM; Gouarin S; Mengelle C; De Wilde A; Cogne N; Champier G; Rogez S; Legendre C; Denis F
J Med Virol; 2004 Aug; 73(4):566-73. PubMed ID: 15221901
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of human cytomegalovirus gene expression in thoracic organ transplant recipients using nucleic acid sequence-based amplification.
Oldenburg N; Lam KM; Khan MA; Top B; Tacken NM; McKie A; Mikhail GW; Middeldorp JM; Wright A; Banner NR; Yacoub M
Transplantation; 2000 Oct; 70(8):1209-15. PubMed ID: 11063343
[TBL] [Abstract][Full Text] [Related]
50. Value of different assays for detection of human cytomegalovirus (HCMV) in predicting the development of HCMV disease in human immunodeficiency virus-infected patients.
Blank BS; Meenhorst PL; Mulder JW; Weverling GJ; Putter H; Pauw W; van Dijk WC; Smits P; Lie-A-Ling S; Reiss P; Lange JM
J Clin Microbiol; 2000 Feb; 38(2):563-9. PubMed ID: 10655346
[TBL] [Abstract][Full Text] [Related]
51. Human cytomegalovirus-associated periodontitis in renal transplant patients.
Nowzari H; Jorgensen MG; Aswad S; Khan N; Osorio E; Safarian A; Shidban H; Munroe S
Transplant Proc; 2003 Dec; 35(8):2949-52. PubMed ID: 14697947
[TBL] [Abstract][Full Text] [Related]
52. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients.
Hernando S; Folgueira L; Lumbreras C; San Juan R; Maldonado S; Prieto C; Babiano MJ; Delgado J; Andres A; Moreno E; Aguado JM; Otero JR
Transplant Proc; 2005 Nov; 37(9):4094-6. PubMed ID: 16386635
[TBL] [Abstract][Full Text] [Related]
53. Analytical performance and clinical utility of a nucleic acid sequence-based amplification assay for detection of cytomegalovirus infection.
Witt DJ; Kemper M; Stead A; Sillekens P; Ginocchio CC; Espy MJ; Paya CV; Smith TF; Roeles F; Caliendo AM
J Clin Microbiol; 2000 Nov; 38(11):3994-9. PubMed ID: 11060058
[TBL] [Abstract][Full Text] [Related]
54. Saliva as a source of HCMV DNA in allogeneic stem cell transplantation patients.
Correia-Silva JF; Bruna-Romero O; Resende RG; Miranda LP; Oliveira FE; Costa FO; Xavier SG; Figueiredo-Neves SP; Almeida HC; Bittencourt H; Gomez RS
Oral Dis; 2010 Mar; 16(2):210-6. PubMed ID: 20374507
[TBL] [Abstract][Full Text] [Related]
55. Diagnostic value of reverse transcription-PCR for detection of cytomegalovirus pp67 in samples from solid-organ transplant recipients.
Meyer-Koenig U; Romberg I; Schneider K; Weidmann M; Kern WV; Hufert FT
J Clin Microbiol; 2006 Sep; 44(9):3394-6. PubMed ID: 16954283
[TBL] [Abstract][Full Text] [Related]
56. Different profiles of cytomegalovirus RNA transcripts and anti-cytomegalovirus IgM antibodies in renal transplant recipients.
Goossens VJ; Vink C; Mullers W; Middeldorp JM; Bruggeman CA
J Clin Virol; 2001 Dec; 23(1-2):87-95. PubMed ID: 11595587
[TBL] [Abstract][Full Text] [Related]
57. CMV infection of liver transplant recipients: comparison of antigenemia and molecular biology assays.
Amorim ML; Cabeda JM; Seca R; Mendes AC; Castro AP; Amorim JM
BMC Infect Dis; 2001; 1():2. PubMed ID: 11389774
[TBL] [Abstract][Full Text] [Related]
58. Early abnormal liver enzyme levels may increase the prevalence of human cytomegalovirus antigenaemia after hematopoietic stem cell transplantation.
Ye B; Zhao H
J Int Med Res; 2017 Apr; 45(2):673-679. PubMed ID: 28415934
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of molecular techniques in prediction and diagnosis of cytomegalovirus disease in immunocompromised patients.
Szczepura A; Westmoreland D; Vinogradova Y; Fox J; Clark M
Health Technol Assess; 2006 Apr; 10(10):1-176. PubMed ID: 16595079
[TBL] [Abstract][Full Text] [Related]
60. Quantitative competitive NASBA for measuring mRNA expression levels of the immediate early 1, late pp67, and immune evasion genes US3, US6 and US11 in cells infected with human cytomegalovirus.
Greijer AE; Adriaanse HM; Kahl M; Tacken NM; Oldenburg N; Sijlmans A; van de Crommert JM; Dekkers CA; Sillekens PT; Middeldorp JM
J Virol Methods; 2001 Aug; 96(2):133-47. PubMed ID: 11445144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
